PHARMAC is pleased to announce decisions to list, delist and amend the restrictions for various pharmaceuticals in Section B or Part II of Section H of the Pharmaceutical Schedule (the Hospital Medicines List), from 1 May 2015. All of these were the subject of a consultation letter dated 9 March 2015.

The proposals were approved essentially as consulted on, with the exception of the following:

• No decision has yet been made on the proposed changes to the Special Authority criteria for dornase alfa. We expect to make a decision on these changes within the next two months.
• Minor amendments were made to the proposed restriction changes for infliximab for severe ulcerative colitis.
• Minor amendments were made to the proposed criteria changes for Fat Modified Products and Food Modules/Nutrient Modules.
• Minor amendments to the product description for multivitamin and mineral supplement.

For more details, go to: http://www.pharmac.health.nz/news/notification-2015-04-16-various-pharmaceuticals/